Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02133703 · ClinicalTrials.gov registry record · NA
Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 369
- Enrollment target
NCT02133703 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 369 participants.
The verdict
NCT02133703, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 369 participants
- Enrollment target
Study Summary
This non-therapeutic trial is for women who have received results of genetic testing for BRCA1/2 mutations. The trial compares decision support tools designed to facilitate informed decision making regarding risk management following testing to usual care. The researchers will test separate decision support tools for women who receive positive test results and women who receive negative/inconclusive test results. Among women who receive a positive test result, an interactive decision support intervention will be compared to a print intervention. Among women who receive an inconclusive result, an interactive intervention will be compared to usual care.
Interventions
- BEHAVIORAL Enhanced Internet DA
- BEHAVIORAL Internet DA
- BEHAVIORAL Enhanced Print DA
- BEHAVIORAL Print DA
- BEHAVIORAL Inconclusive Results DA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2015-10 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02133703
The ClinicalTrials.gov registry entry for NCT02133703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Enhanced Internet DA is the first listed.
NCT02133703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02133703 about?
NCT02133703 is a clinical study titled "Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility". This non-therapeutic trial is for women who have received results of genetic testing for BRCA1/2 mutations. The trial compares decision support tools designed to facilitate informed decision making regarding risk management following testing to usual care. The researchers will test separate decision...
What is the current status of trial NCT02133703?
This trial is currently completed. It is a NA study. The enrollment target is 369 participants. The study started on 2015-10. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT02133703?
The interventions under investigation include: Enhanced Internet DA (BEHAVIORAL), Internet DA (BEHAVIORAL), Enhanced Print DA (BEHAVIORAL), Print DA (BEHAVIORAL), Inconclusive Results DA (BEHAVIORAL).
Who is sponsoring clinical trial NCT02133703?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.